Diabetes drug metformin shows promise for glaucoma blindness prevention
NCT ID NCT05426044
First seen Nov 20, 2025 · Last updated May 09, 2026 · Updated 23 times
Summary
This study tests whether metformin, a widely used diabetes medication, can slow down vision loss in people with glaucoma. Researchers will give 125 adults with progressive glaucoma either metformin or a placebo for 24 months. The goal is to see if metformin can protect the optic nerve beyond simply lowering eye pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HKU Eye Centre
RECRUITINGWong Chuk Hang, Hong Kong
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.